Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte’s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense. For more information, visit www.Humacyte.com.
View Top Employees from HumacyteWebsite | http://www.humacyte.com |
Revenue | $112 million |
Funding | $437.9 million |
Employees | 186 (186 on RocketReach) |
Founded | 2004 |
Address | 2525 E NC Highway 54, 2525 E Hwy 54, Durham, North Carolina 27713, US |
Phone | (919) 313-9633 |
Fax | (919) 313-9634 |
Technologies |
JavaScript,
HTML,
PHP
+43 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Medical, Health Care, Medical Device |
Web Rank | 6 Million |
Keywords | Tissue Engineering, Regenerative Agriculture, Organ And Tissue Donation |
Competitors | AVITA Medical, Advanced Tissue, Pinnacle Transplant Technologies, Tissue Regenix Group, axogen |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 33 Companies, NAICS Code 541 Companies |
Looking for a particular Humacyte employee's phone or email?
The Humacyte annual revenue was $112 million in 2024.
Laura Niklason is the President and Chief Executive Officer of Humacyte.
186 people are employed at Humacyte.
Humacyte is based in Durham, North Carolina.
The NAICS codes for Humacyte are [54, 33, 541].
The SIC codes for Humacyte are [87, 873].